Chelsea Therapeutics International (CHTP)
Chelsea Therapeutics International Revenues
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these CHTP related companies
CHTP News
@HighRiskBuyer @Lucasm82 $CHTP no date given but results out soon CH-1450 probably this coming week! Either good or bad! We shall see!!!
about 2 days ago by BiopharmaPro
about 2 days ago by BiopharmaPro
RT @Lucasm82 $CHTP Anyone know when we could hear results next week on phase II CH-4051?no date given. u'll know when this opens big or bad.
about 3 days ago by HighRiskBuyer
about 3 days ago by HighRiskBuyer
$CHTP Anyone know when we could hear results next week on phase II CH-4051?
about 3 days ago by Lucasm82
about 3 days ago by Lucasm82
RT @tweetingstocks $CHTP HOD working its way no position in either at the moment. On my watchlist __ People waiting for CH-4051 news, binary
about 4 days ago by Glopolon
about 4 days ago by Glopolon
$CHTP HOD and $ARNA working its way no position in either at the moment. On my watchlist
about 4 days ago by tweetingstocks
about 4 days ago by tweetingstocks
$CHTP peeps proving me wrong so far. I thought this dropped more before any move up. Good for you.
about 4 days ago by tweetingstocks
about 4 days ago by tweetingstocks
$CHTP This thing should explode on positive news because it is so beatin down.
about 4 days ago by Lucasm82
about 4 days ago by Lucasm82
$CHTP Finally some green. Lets hope for some big green in the next week or so.
about 4 days ago by Lucasm82
about 4 days ago by Lucasm82
$CHTP knows how to disappoint. RA data must be stellar if it has any hope of recouping some of its share price before extended 306B data
about 5 days ago by elysian
about 5 days ago by elysian
$chtp sry to keep going but another piece of info. http://stks.co/3xrw Chelsea is 90/10 long%, wonder if we'll just go straight to $2 tmrw?
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
$chtp http://stks.co/3xrH unfortunately they don't mention chelsea directly.
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
$CHTP http://stks.co/3xbs Follow link for new SA article if haven't read it yet. I'm thinking positive results brings this to $3 in a week.
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
$CHTP Turning up here with the market is a good thing. Means it was only selling off from market being down. I'm still holding off myself.
about 5 days ago by tweetingstocks
about 5 days ago by tweetingstocks
RT @tweetingstocks $CHTP It does seem like it will never stop but this is really oversold now. I'm happy putting money here at this level.
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
$CHTP I know it looks tempting to buy today. I almost bought myself again. I think it still has some to fall.
about 5 days ago by tweetingstocks
about 5 days ago by tweetingstocks
Hehe, $chtp 3 month chart looks like a boot. Added here only today. If trend continues, soon this really will be a 10 bagger lol.
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
RT @Jmdevrie $CHTP Anyone know how this is down so much on so little volume?! __ Everyone selling no one buying, market jitters.
about 5 days ago by Glopolon
about 5 days ago by Glopolon
$CHTP http://stks.co/3x4h I'm adding today after over reaction, CH-4051 good results IMO, all else = stock should not be trading under 2.
about 5 days ago by HighRiskBuyer
about 5 days ago by HighRiskBuyer
@Lucasm82 $CHTP while a setback moving Northera is a good thing as they can submit another filing with the new NDA! Selling was overdone imo
about 6 days ago by BiopharmaPro
about 6 days ago by BiopharmaPro
Chelsea Therapeutics (CHTP) Completes End-of-Review Meeting with FDA Over Northera NDA
May 22, 8:07AM Street Insider
May 22, 8:07AM Street Insider
Pomerantz Law Firm Reminds Shareholders of Chelsea Therapeutics International Ltd. of Upcoming Deadline -- CHTP
May 11, 1:02PM GlobeNewswire
May 11, 1:02PM GlobeNewswire
CORRECTING and REPLACING -- Chelsea Therapeutics Reports First Quarter 2012 Results
May 01, 4:46PM GlobeNewswire
May 01, 4:46PM GlobeNewswire
Pomerantz Law Firm Reminds Shareholders of Chelsea Therapeutics International Ltd. of Upcoming Deadline -- CHTP
Apr 27, 11:57AM GlobeNewswire
Apr 27, 11:57AM GlobeNewswire
Chelsea Therapeutics to Present at the 19th Annual Future Leaders in the Biotech Industry Conference
Apr 20, 7:00AM GlobeNewswire
Apr 20, 7:00AM GlobeNewswire
Pomerantz Law Firm Has Filed a Class Action Against Chelsea Therapeutics International Ltd. -- CHTP
Apr 12, 2:28PM GlobeNewswire
Apr 12, 2:28PM GlobeNewswire
Faruqi & Faruqi, LLP Announces Investigation of Chelsea Therapeutics International, Ltd.
Apr 05, 7:15PM PR Newswire
Apr 05, 7:15PM PR Newswire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Chelsea Therapeutics International, Ltd.
Apr 05, 6:30PM Business Wire
Apr 05, 6:30PM Business Wire
Class Action Lawsuit Filed by Law Offices Bernard M. Gross, P.C. Against Chelsea Therapeutics Int'l Ltd. -- CHTP
Apr 05, 8:47AM GlobeNewswire
Apr 05, 8:47AM GlobeNewswire
Pomerantz Law Firm Has Filed a Class Action Against Chelsea Therapeutics International Ltd. -- CHTP
Apr 04, 3:53PM GlobeNewswire
Apr 04, 3:53PM GlobeNewswire
Chelsea Therapeutics to Present at 11th Annual Needham Healthcare Conference
Apr 02, 7:30AM GlobeNewswire
Apr 02, 7:30AM GlobeNewswire
Needham & Company Downgrades Chelsea Therapeutics (CHTP) to Hold; Receives Complete Response Letter for Northera
Mar 29, 3:22PM Street Insider
Mar 29, 3:22PM Street Insider
Deutsche Bank Downgrades Chelsea Therapeutics (CHTP) to Hold; Uncertainty & Risks Building
Mar 29, 10:14AM Street Insider
Mar 29, 10:14AM Street Insider
Chelsea Therapeutics (CHTP) volatility elevated at 192; FDA asks for more efficacy data
Mar 29, 9:03AM Street Insider
Mar 29, 9:03AM Street Insider
Chelsea Therapeutics (CHTP) Slammed on FDA Complete Response for Northera Caps
Mar 29, 7:47AM Street Insider
Mar 29, 7:47AM Street Insider
Chelsea (CHTP) Gets Complete Response from FDA for Northera; Additional Data Needed
Mar 29, 6:35AM Street Insider
Mar 29, 6:35AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CHTP | 1.87 | -0.03 | -1.58% | 125.36M |
| CHT | 30.48 | -0.14 | -0.46% | 23.64B |
| CHSP | 17.78 | +0.17 | +0.97% | 571.27M |
| CHSI | 87.63 | +1.29 | +1.49% | 4.403B |
| CHS | 15.16 | +0.06 | +0.40% | 2.539B |
| CHRW | 59.69 | -0.13 | -0.22% | 9.731B |
| CHRS | 7.33 | +0.00 | +0.00% | 854.16M |
| CHRM | 7.28 | +0.08 | +1.11% | 283.77M |
| CHOP | 2.61 | -0.04 | -1.51% | 155.11M |
| CHNR | 6.875 | +0.41 | +6.26% | 171.26M |
